Found 15 matching trials
Adebrelimab Combined With Chemoradiotherapy in Patients With Large Bulky Stage III Unresectable Non-Small Cell Lung Cancer PHASE3 This is a randomized, controlled, multicenter clinical study that enrolled ...
Show More Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
A Phase II Single-arm Clinical Study in the Treatment of Locally Advanced Esophageal Cancer After Failed Neoadjuvant Chemoimmunotherapy PHASE2 The goal of this clinical trial is Iparomlimab and tuvonralimab (QL1706) co...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and Surgery for Resectable Esophageal Squamous Cell Carcinoma(CRIS-2 Trial) PHASE2 Based on our previous single-arm Phase Ib study (CRIS trial, NCT06303583), ...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC PHASE2 It is a prospective, open-label, randomized, controlled phase II/III clinic...
Show More Location
Anhui Provincial Cancer Hospital
Learn More & Join Trial
A Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China PHASE2 Nivolumab (BMS-936558) is a fully human, IgG4 (kappa) isotype mAb that bind...
Show More Status
Active Not Recruiting
Location
Guangdong Lung Cancer Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences
Learn More & Join Trial
Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT) PHASE2 Previous studies confirmed locally advanced oral/oropharyngeal squamous cel...
Show More Status
Active Not Recruiting
Location
Peking University School and Hospital Stomatology
Learn More & Join Trial
A Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for EC NA Esophageal cancer is a high - incidence cancer type in China, characterized...
Show More Status
Enrolling By Invitation
Location
Cancer Hospital, Chinese Academy of Medical Sciences/Peking Union Medical College
Learn More & Join Trial
A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC PHASE2 To evaluate the efficacy and safety adebrelimab in Combination with chemoth...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer PHASE2 In the global landscape of cancer, head and neck malignancies are highly pr...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Induction Chemotherapy and Toripalimab Followed by Chemoradiotherapy for Large-volume Local Advanced NSCLC PHASE2 This study is a Phase II study to evaluate the clinical efficacy and safety...
Show More Status
Active Not Recruiting
Location
Chinese Academy of Medical Science and Peking Union Medical College
Learn More & Join Trial